Additionally, the exposure scenario, including the mode of entry into the environment (i.e. through 50 air, water or sediment) appears to be an important determinant of the level of agreement between 51 modeling approaches. 52
INTRODUCTION

54
The U.S. Environmental Protection Agency (EPA) regulates chemical substances based on their 55 potential to cause human health and ecological risk. EPA's risk-assessment practices, which provide 56 the scientific foundation for regulatory decisions, continue to follow the recommendations by the 57 National Research Council (NRC (National Research Council) 1983), calling for scientific rigor in 58 characterizing an agent's hazard, dose-response, exposure and effects.. The paucity of sufficient 59 information to evaluate chemical exposure and effects led to the NRC's evaluation of this process 60 and a call for a more integrated assessment of exposure and toxicity (NRC 2009 ). The NRC's 61 recommendations directly relates to risks presented from chemical substances found in products 62 and materials used by society. 63
64
The primary purpose of the Toxic Substances Control Act (TSCA) is "to assure innovation and 65 commerce in such chemical substances and mixtures do not present an unreasonable risk of injury 66 to health or the environment" (TSCA § 2 (b)(3)). At present, an unprecedented and increasing 67 number of chemicals for which risks must be assessed, at least at some screening level, continue to 68 be added to the TSCA inventory (over 80,000) . Approximately 100,000 chemical substances 69 currently exist in commerce worldwide (Muir and Howard 2006) . Hence, the urgent need for new, 70 broadly applicable tools to facilitate rapid risk characterization (Dix, Houck et al. 2007 ) is widely 71 recognized and has been well established in the literature. The U.S. is certainly not alone in this 72 effort, as legislated mandates for efficient risk based screening, categorization, classification and 73 prioritization of chemicals exist in the European Union and Canada as well (Egeghy, Vallero et al. 74 2011) . 75
76
High throughput screening models are needed for both hazard (toxicity) and exposure, since risk is 77 a function of both. Current advances in hazard utilize computational chemistry and in silico 78 methods for high-throughput screening (HTS) and various toxicogenomic methodologies. These 79 have accelerated the prediction of potential toxicity for prioritization by providing a greater 80 quantity and diversity of data. Notably, EPA's ToxCast™ program applies a battery of rapid in vitro 81 assays to predict toxicity. To complete the high throughput risk screening, however, exposure 82 information must also be acquired in a similarly rapid manner, and compared with results from 83 ToxCast™. Thus, there is a need to rapidly assess chemicals on the basis of 'biologically-relevance' 84 human exposures to target research and improve risk assessments (Cohen Hubal, Richard et al. 85 2010) . In 2009, EPA launched its ExpoCast™ initiative to address this need for exposure data, novel 86 modeling approaches and discriminating metrics to screen and evaluate chemicals based on 87 potential for human exposures [Cohen Hubal, Richard et al. 2010)] . 88
89
The use and development of exposure models as well as expert judgment have aided in the 90 endeavor to screen and prioritize chemicals when exposure measurements are limited or 91 unavailable (Schinkel et al 2011 , Jayjock et al 2009 . In its 1995 review of the state-of-the-science, 92 the Society of Environmental Toxicology and Chemistry found that the chemical ranking and 93 scoring systems developed over the previous 20 years were widely diverse in the factors used for 94 screening potential exposure, including: (1) chemical marketing data; (2) emission data; (3) 95 physical-chemical properties; (3) persistence and transformation processes; (4) monitoring data or 96 other measured concentrations; (5) modeled or estimated concentrations; (6) receptor 97 characteristics and exposure setting -including consumer, worker exposure related to frequency, 98 duration, and intensity; and (7) exposure expressed as intake (Swanson and Socha 1997) . More 99 recently, Egeghy and coauthors review modeling tools and approaches available for prioritizing 100 manufactured chemicals. These approaches tend to fall into two categories: the first focuses on 101 characterizing the fate and transport of a chemical following release into the environment, while 102 the second focuses on understanding exposures resulting from use and interaction with consumeron potential for exposure. The objective of the challenge was to gain a better understanding of the 128 process by which existing approaches evaluate potential exposures. As such, the main interest was 129 in an explicit and transparent documentation of each approach. Employing existing tools further 130 facilitates an analysis identifying the type, quantity and quality of information needed for a more 131 comprehensive approach toward exposure-based prioritization. 132
QUANTITATIVE EXPOSURE METRICS 133
Metrics for assessing chemical exposure and exposure potential referred to in the present 134 study are the intake rate (iR; e.g., µg/d or kg/h), the intake fraction (iF; e.g., kg-intake/kg-emission), 135 and the concentration in an organism such as a human (C; e.g., µg/kg). If desired, the intake rate can 136 also be calculated on a body weight basis (iR BW ; e.g., µg kg-bw -1 day -1 ). These metrics can be 137 calculated using a consistent, arbitrary "unit emission" rate (E U ; e.g., kg/h) for all chemicals to 138 screen, compare and prioritize chemicals based on relative exposure potential, i.e., using iF or C U . 139
The steady state intake rate based on a unit emission rate (iR U ; kg/h) provides similar screening 140 and ranking information as the steady state intake fraction iF since the intake fraction is the 141 chemical intake rate normalized to the emission rate, i.e., iF = iR/E. The iF can be calculated on an 142 individual basis, an age-class specific basis (iF AC , e.g. "toddlers" vs. "adults"), or for a human 143 population in a defined spatial region (iF POP ). The latter two iF endpoints are thus dependent on 144 population and demographic information. Intake rates and intake fractions can include the sum of 145 all exposure routes (i.e., aggregate exposures) or they can be calculated for specific sources (i.e., for 146 air, water, and food stuffs individually) to compare the relative importance of different exposure 147 routes and to identify those routes of exposure that are expected to be highest for a particular 148 chemical. Relative exposure potential metrics are thus independent of an actual emission rate and 149 are useful for chemical screening evaluations due to the substantial uncertainty in actual emission 150 rate estimates. Relative exposure potential comparisons are a function of the chemical andenvironmental properties (persistence, bioaccumulation) and the underlying assumptions and 152 parameters used to characterize the environmental and human conditions in the models. 153
Alternatively, exposure metrics can be calculated using estimates of "actual emission" rates 154 (E A ; e.g., kg/h), thus providing indices for screening and priority setting based on actual exposure 155 estimates, i.e., C A or iR A. Estimates of actual chemical exposure using concentrations or intake rates 156 are directly applicable in risk based chemical assessments by comparing body/tissue 157 concentrations or intake rates of exposures with those concentrations or rates of intake associated 158 with effect or no effect levels. Unlike iR A and iF, C is an internal dose metric and therefore it depends 159 on absorption (i.e. including gastrointestinal biomagnification from dietary exposures) into the 160 body and elimination processes such as fecal egestion, urinary excretion, respiratory exhalation, 161
and importantly for most chemicals, metabolic biotransformation. 162
SEMI-QUANTITATIVE METRICS 163
A set of semi-quantitative measures of potential exposures to the chemical of concern are also 164 presented as a part of a tiered screening approach. These metrics are based on a combination of 165 available quantitative information on releases and concentrations, qualitative information on types 166 and degree of exposures reported in the literature, and expert judgment on various facets of the 167 exposures. The four population-based metrics considered for exposure based ranking are: 168 pervasiveness, persistence, severity, and efficacy. The semi-quantitative metrics reflect: (i) how 169 widespread the exposures could be within the general US population (pervasiveness); (ii) the 170 temporal frequency and/or duration of such exposures (persistence); (iii) the potential for high 171 levels of such exposures (severity); and (iv) the potential of the contact with the chemical to result 172 in intake/uptake (efficacy). 173
CHEMICALS 174
A set of 52 chemicals (or defined mixtures) was provided (Table 1) . These chemicals are 175 representative of several broad categories in terms of physical-chemical properties and typicalintended use. Thus, exposure to these substances can be assessed across multiple routes and 177 pathways depending on the prioritization model or approach. The majority of the set is comprised 178 of chemicals known to have a relative abundance of publically available exposure-related data 179 accessible for modeling; conducting this pilot from a 'data rich' perspective was intended to limit 180 the burden of data collection. Several chemicals with meager available exposure data, however, 181
were also included to test the capabilities of the models for addressing the vast majority of 182 chemicals in wide commercial use with little or no existing exposure-related information (Egeghy 183 et al., 2011b however, the metrics from the different approaches were not always directly comparable. Some of 224 the endpoints used in the comparisons below are "exposure potential" i.e., intake fractions and 225 some are "exposure" endpoints, i.e., internal concentrations or body burdens. (For more 226 information on exposure metric development the reader is directed to Rosenbaum et al 2008 , 227 Bennett et al 2002 , and Arnot et al 2010 .) The modeling approaches also used different model input 228 parameters for chemical properties, use and release rates. Based on the exposure metrics, the 229 chemicals were ranked according to magnitude thereby creating ordinal values from the measured 230 or modeled values with monotonic differences between chemical exposure ranks. While this is a 231 convenient way to view relative rankings between chemicals we note that with this approach some 232 information is lost because of the transformation. For example, multiple chemicals may have 233 fractional differences in the value of the exposure metric, but once transformed these differencesbecome exaggerated by the ordinal scale. For the purpose of prioritization, the utility of the lost 235 information may be considered negligible as it is not the intent of these applications to produce 236 precise measures of exposure. The actual values of the exposure metrics were however used to 237 assess the degree of differentiation between chemicals in results from each approach. This is of 238 interest especially when uncertainty around the estimates is considered. For example, if many 239 chemicals have the same exposure estimates, which is a possible artifact of using default values for 240 missing data, the ability of the approach to separate high, low and moderate exposure potential will 241 be impaired. This topic is included in the qualitative discussion of the results. Table 2 summarizes 242 the comparisons conducted in this analysis based on the compatibility of the exposure metrics 243
provided. 244
The quantitative analysis consisted of four methods: 245
Correlation between the ranks of each chemical produced by the models was assessed 246 using two non-parametric measures of rank correlation, Spearman rho and Kendall tau. 247
The Spearman rank correlation indicates the direction of association between two 248 variables that can be related by any monotonic function. The Kendall tau correlation 249 depends on the ratio of concordant pairs to discordant pairs or the number of 250 inversions needed to transform one rank order into the other. The Kendall tau 251 coefficient can be interpreted probabilistically as the difference between the probability 252 of the set of ranked objects being in the same order and the probability of the ranked 253 objects being in a different order. (Abdi 2007) While in most cases, the Spearman rho 254 produces a higher correlation coefficient than the Kendall tau, the two measures can 255 yield meaningfully different results. Spearman's rho is more sensitive to a few large 256 deviations than Kendall's tau. This information can be useful if one wants to consider 257 using several modeling approaches in combination to form a consensus ranking for each 258 chemical in the future; therefore both correlation measures were evaluated. Chemicalsnot ranked by a particular model were eliminated from the correlation analyses and the 260 remaining chemicals were re-ranked relatively. 261
The chemicals were sorted into 5 equally distributed bins based on their ranks. 262
Correlation among the bin designations was assessed along with the expert judgment 263 driven semi-quantitative metrics of exposures from PRoTEGE. 264
To evaluate consistency among the modeling approaches without considering the 265 
RESULTS
279
COMPARISON OF EVALUATION SCHEMES/MODELS 280
We briefly summarize a qualitative comparison of the aforementioned model characteristics to 281 provide context for the prioritization results, though this study focuses on the metrics utilized for 282 prioritization (exposure estimates and rankings) from each approach without regard to theunderlying purpose, algorithm and assumptions involved in each. RAIDAR, FHX and USEtox are far-284 field models representing exposure from diffuse sources to the general human population of 285 different regional spatial scales. These three models use mechanistic mass balance approaches to 286 simulate fate and transport in different environmental compartments. Models for bioaccumulation 287 into food sources destined for human consumption are also included in the exposure pathways. The 288 intake fraction or mass of substance available for contact with an organism per mass emitted to the 289 environment was identified as the primary metric for exposure based prioritization from these 290 models. Additionally, intake rate from the RAIDAR and FHX models can be used. The FHX model 291 provides age class specific rankings for chemicals, but these were not significantly different than 292 the rankings for the adult age class so they were not included in our comparative analysis. 293
Additionally only the RAIDAR model includes absorption, distribution, metabolism and excretion 294 (ADME) processes and an internal concentration in humans as a metric for prioritization. While this 295 metric may be considered most 'biologically relevant' and compatible with toxicity data some 296 technical issues have been noted elsewhere in regards to corroborating this metric against 297 measured biomarkers (Georgopoulos, et al. 2009 ). For simplicity, each of the far field models can be 298 run based on an equivalent unit emission and equilibrium assumption for each environmental 299 compartment to provide a relative estimate for each chemical or with more advanced fate 300 assumptions. This approach may be useful for making comparisons among broad ranges of 301 chemicals for which actual emission data is unavailable though this contributes more uncertainty in 302 the chemical screening. Under the unit emission assumption, RAIDAR and FHX provided rankings 303 for 45 chemicals and USEtox provided rankings for 42 chemicals. When actual US emission 304 estimates were possible, USEtox estimated exposures for 29 chemicals and RAIDAR estimated 305 exposures for 10 chemicals (though actual EU emission rates were available for the remainder of 306 the chemicals assessed by RAIDAR). 307
Intake is an intermediary variable in USEtox to be coupled with toxicity to form a combined 309 exposure/toxicity "damage" endpoint. The intake value from USEtox alone is not considered a 310 suitable metric for ranking but provides a means of comparison on the basis of exposure. The three 311 far-field models can be parameterized with chemical specific information from measurement 312 databases or estimated from readily available Quantitative Structural Activity Relationship (QSAR) 313
models. 314 315
The EFAST model provides similar far-field modeling estimate, but also considered risk 316 management interventions to reduce exposure. It also includes a consumer product module. 317 EFAST2 is a screening-level computer tool that allows users to generate exposure estimates for 318 humans and the environment through various release and exposure scenarios. The chemical-319 specific input parameters (mostly physicochemical properties) used in the EFAST2 model include: 320 1) bioconcentration factor (BCF; L/kg), 2) concentration of concern (CoC; ppb), 3) wastewater 321 treatment removal rate (WWT; %), 4) incineration removal rate (%), 5) fugitive removal rate (%), 322 6) ground water migration rate, 7) molecular weight (g/mol), 8) vapor pressure (mm Hg), and 9) 323 weight fraction (%). The modeling endpoints estimated with EFAST2's General Population and 324
Ecological Exposure from Industrial Releases module include the human Acute Dose Rate (ADR in 325 mg/kg-day) and LADD (Lifetime Average Daily Dose (LADD in mg/kg-day) for exposures from 326 drinking water (via surface water releases), groundwater ingestion (via landfill releases), fish 327 ingestion (via surface water releases and subsequent bioconcentration), and inhalation (from stack 328 and fugitive air releases). 329
330
The far-field modeling approaches produced the most rapid results of those evaluated in this study, 331 primarily because of the ease of parameterization using available chemical specific properties. 332 3.1.1 RAIDAR 334 RAIDAR was used to estimate exposure for X number of challenge chemicals. Figure 1 shows the 335 unit emission based chemical results produced by the RAIDAR model on the basis of individual 336 intake fraction (IF) and internal concentration (Cu) at Tier 1Level II fate model calculations. These 337 assumptions do not require a model of entry into the environment as they assume instantaneous 338 equilibrium in all physical compartments. The results in Figure 1 highlight the increase in 339 differentiation among chemicals when ADME processes are included (~12 orders of magnitude 340 when included vs. ~6 orders when not included). ADME processes made a significant difference in 341 relative rankings for those chemicals predicted to have moderate exposures levels. For those 342 predicted to have either very low or very high exposure levels, results from both internal and 343 external exposure metrics were highly correlated. In RAIDAR this difference was a more significant 344 factor in differentiating potential exposures than the assumed emission release compartment (i.e. 345 air, water or soil) which is unknown for many chemicals recommendations comprehensive 346 pathway (Wenger et al., 2012) . Because human exposure to manufactured chemicals in consumer 355 products is of concern, an indoor compartment will improve relevance of screening-level model 356 predictions. 357
EFAST 359
The EFAST2 model produced results for 48 chemicals for water releases only. Each exposure 360 scenario (drinking water, fish ingestion, and groundwater/landfill routes) was ranked separately 361 and the chemicals were assigned a relative score (1-4) based on the distribution of their dose estimates 362
For comparison with USEtox and RAIDAR the dose estimates for emission to water were combined 363 and each chemical was ordinally ranked. Since the model was developed for screening level 364 estimates, the results are highly conservative and rely on many default values. In comparison with 365
USEtox and RAIDAR the temporal scale of the release conditions also differs in EFAST2. Where 366
USEtox and RAIDAR assume steady state releases, the EFAST2 model can evaluate exposures from 367 several different temporal release patterns. For this evaluation a unit emission was considered for a 368 twenty day period to produce exposures measured in ADR and LADD as described above. Because 369 of the assumptions used in this relative analysis of chemicals, both the ADR and LADD estimates 370 were perfectly correlated, so only the LADD values are used in the following comparative analysis. 371
An example of the EFAST2 results for the total exposure from water releases is illustrated in Figure  372 3. Differentiation of estimates spanned 4 orders of magnitude. Additional results from EFAST 373 included 9 chemicals ranked using the consumer module. These estimates are calculated solely 374 from inhalation (no other route) using given chemical-specific inputs of molecular weight and vapor 375 pressure. Only 11 chemicals were identified to have potential household consumer applications 376 (that fit within the EFAST model), two chemicals were excluded because they did not include an 377 inhalation assessment (this is the case when only the bar soap scenario applied). The consumer use 378 scenarios applied to the chemicals assessed include: (1) general purpose cleaner; (2) bar soap; (3) 379 laundry detergent; and (4) latex paint. 380 3.1.4 GExFRAME 381 GExFRAME and PRoTEGE provided rankings for microenvironmental exposures, though both used 382 different approaches. PRoTEGE is based on a more sophisticated predecessor, MENTOR (Modeling 383 ENvironment for TOtal Risk) and estimates both near-field and far-field exposures. MENTORsupports detailed person-oriented source-to-dose exposure modeling for mixtures of multimedia 385 contaminants, allowing a focus on specific locations and subpopulations. Neither MENTOR nor 386 GExFRAME are considered single models. Both are modeling systems or modeling environments 387 capable of accommodating various algorithms to integrate scientific data and models for estimating 388 exposures. For this analysis, the CARES (Cumulative and Aggregate Risk Evaluation System) 389 program was integrated with GExFRAME to assess dietary and non-dietary residential exposures. 390
The results from the use of GExFRAME in this exercise were purely qualitative and could not be 391 included in the quantitative analysis. Chemicals used in consumer products were grouped into 392 scenarios that defined similar source characteristics, media dispersion characteristics and exposure 393 pathways. Based on these categories a scenario specific set of exposure algorithms were assigned. A 394 default set of inputs are available for conducting exposure assessments within each set of 395 algorithms. The 52 challenge chemicals were classified as described in Table 4 . 396
397
The GExFrame analysis produced only categorical values because GExFrame requires measured or 398 monitored data in near field exposure media, e.g. breathable air, contact surfaces, ingestible soil, 399 dust in air and surfaces, food and drinking water and other near field information. That is, 400
GExFrame is designed to provide a high tier, low throughput chemical characterization. Exposure potential characterization is also use for prioritizing chemicals in terms of need for 407 further testing. Thus, chemicals in Category 6, notwithstanding their high exposure, may beconsidered lower priority because much is known about the chemical class in general and higher 409 tiered models are available to produce more accurate results. 410
SHEDS 411
The US EPA SHEDS model was determined to be useful for screening chemicals when specific use 412 categories and scenarios could be established. Parameterization of the model could be conducted 413 using default values, but this was not the intended purpose of such high tier models so it presented 414 some challenges. Future work to modify the SHEDS model for lower tiered assessments is required. chemicals of concern using probability distributions of multimedia contaminant concentrations, 439 combined with distributions of physiological and behavioral factors. These metrics are primarily 440 based on available nationwide data and are summarized in Figure 5 . The exposure estimates 441 spanned 6 to 10 orders of magnitude differentiating among the chemicals evaluated before they 442 were transformed into categories. Time to obtain these chemical specific data points may be 443 excessive when applied to larger sets of chemicals for screening and prioritization purposes. 444
445
Results from PRoTEGE were provided for 55 chemicals in Tier 1 -those listed in Table 1 and  446 additional perchlorate salts -sodium perchlorate, potassium perchlorate, and magnesium 447 perchlorate. In Tier 2, estimates were obtained for 47 chemicals -both median values and 95 th 448 percentile estimates were provided. 449
COMPARISON OF PRIORITIZATION RESULTS 450
Actual Emissions 451
Comparison between the prioritization results were only made where they were deemed 452 appropriate as described in Tables 2, 3a and 3b -with similar emission assumptions, modes of 453 entry, etc . While RAIDAR and USEtox mainly provide estimates of exposures due to environmental 454 releases versus exposure due to indoor sources or consumer product use exposure estimates, 455
PRoTEGE estimates are equivalent to intakes for the general population and therefore provide a 456 means of comparison with RAIDAR and USEtox. In other words, although the model structures are 457 different, the exposure metric is similar and therefore these three models can be compared. In qualitative metrics, the ingestion pathway is inversely related to the dermal and inhalation 495 pathways along with the aggregate or dominant pathways which are influenced by these measures.
Unit Emissions
Due to lack of actual emission data for a large number of chemicals, more compounds could be evaluated using a unit emission rate. RAIDAR, USEtox and EFAST produced rankings based on unit emissions to water for 38 chemicals. The Spearman rho correlation is reported in Figure 8 . Positive correlation was observed between all measures. RAIDAR and USEtox intake fractions were highly associated with a Spearman rho of 0.7. EFAST2 produced results that were associated with both USEtox and RAIDAR to a lesser extent (Spearman rho = 0.3). The major difference between the later approach and the former approaches is the inclusion of chemical specific removal rates from environmental media. The Kendall tau values were also consistently lower so they are not reported.
A strong association was also revealed between the intake fraction and internal concentration metrics from RAIDAR. This indicates that the inclusion of ADME may be unnecessary at the prioritization stage. However it should be noted that most of the chemicals here are "legacy pollutants" ( i.e. persistent). A different pattern may exist for the larger domain of chemicals requiring evaluation.
When rankings based on air emissions were compared (Figure 9 ), very high association was observed between RAIDAR and USEtox. Comparison of the intake fractions for 38 chemicals resulted in a Spearman rho of 0.9.
To avoid bias from the gross aggregation of source compartments that may affect the rankings, intake fractions for ingestion and inhalation of air and water were disaggregated for comparison.
Areas of departure between far-field models (USEtox in contrast with RAIDAR and FHX) are the result of differences in (i) model input parameters (model users did not use consistent input parameters)), (ii) treatment of release (emission) rates to population densities, and model structure (e.g., differences in fate and food web calculations as well as human contact rates (i.e. diets).Only a comparison between models with consistent model input parameters established for each can shed light to the cause of the observations here , but it useful to see which domains of information and metrics yield similar results.
The Friedman test compares three or more paired groups. The test allowed for comparison between model outputs while separating sources variability. The two major sources of variability are the individual chemical being modeled and the model used for prioritization (e.g. RAIDAR, USEtox, Protégé, EFAST, etc.). Based on the total of 38 chemicals evaluated by each model using the unit emission rate, this Friedman test can identify consistency among approaches aggregately rather than pairwise. This analysis answers the question "Are the models' rankings consistent with each other? " or "Are some models ranking chemicals consistently higher or lower than other. In every case the null hypothesis, equal treatment by each model, could not be rejected meaning that there is some consistency between modeling results. The results are summarized in Table 6 . While the actual ranking scores of each chemical are dissimilar (as indicated through correlation tests), consistency exists between approaches in a broader sense based in the Friedman test which may indicate that it is appropriate to combine approaches to form a consensus ranking.
Discussion
Overall the statistical comparisons reveal that between the far-field models viewed here, RAIDAR, FHX and USEtox, there is close agreement between chemical rankings when the emission compartments are consistent (i.e. water and air). The case study results from these models are dependent on the emissions rates as drivers of the modeling results so expected differences were observed when these inputs were varied from the unit emission assumption. When compared to near field models (PRoTEGE) a significant indication of agreement between rankings exist when the emission estimates are regionally compatible (i.e. U.S. release inventories). Unfortunately, these actual release quantities are unavailable for a large number of chemicals produced at lower production volumes. Inverse relationships between the qualitative estimates informed in part by expert judgment and the quantitative modeling results were observed to be sensitive to exposure pathway. This is an indication that scenario specific chemical rankings may be important going forward. Another finding to support the need to resolve scenario specific exposure prioritization issues is that within the USEtox modeling results, the rankings of chemicals from the indoor air pathway and outdoor air pathway had a very low inverse Spearman correlation coefficient of -0.18 as well. Time activity data has shown that the population spends most of their time indoors including residential and occupational settings. Therefore the need to include exposure predictions for near-field exposure is significant. Models like GExFRAME and SHEDS are designed to make these scenario dependent predictions, however they are incapable of producing results for a large number of chemicals lacking the sufficient input data for higher tiered assessments. It is clear that characterizing important factors like habits and practices of consumers which drive exposure potential is a critical need. The PRoTEGE model allows for lower tier predictions to capture these factors in a "data poor" environment with semi-qualitative metrics. Where more data are available, median higher tier predictions of exposure potential based on quantitative assessments showed moderate agreement with the RAIDAR model but inverse association with USEtox and Protégé.
While these types of metrics offer a promising alternative in the absence of data, it will be important to reconcile the differences between the semi-quantitative and modeled results in terms of specific exposure pathways which appear to be the most significant contributor to the observed differences.
Ultimately the reliability and utility of these approaches is dependent on their ability to rapidly assess thousands of chemicals for which little exposure information is anticipated. Developing a set of criteria or specific needs from a high throughput exposure based prioritization approach is a necessary precursor. The objectives of such an approach are needed to more clearly define how to balance the tradeoffs between producing rapid results with available information and meeting an acceptable level of confidence in screening. For example, the categorization of chemicals seen here for GExFRAME and SHEDS could be useful in eliminating chemicals from an inventory because of little concern over potential exposure though they do not produce individual exposure estimates.
Additionally, these approaches may be parameterized with defaults to shed light on the relevance or potential exposure associated with particular scenarios. The developers of EFAST2 and PRoTEGE, approaches which did produce exposure estimates recommended binning the results into 4 or 5 risk categories based on associated confidence. The term prioritization infers the need to have chemical specific ordinal results but the ability to 'screen for prioritization' should not be necessarily discounted. How comprehensively exposure across the source to receptor continuum is characterized is another issue that needs to be resolved. The far-field models were more inclusive of processes relevant to the entire continuum (though they were more rigorous in processes from source to concentration). The near field models rely on environmental concentrations from scenario specific use of chemicals and focus more on the successive processes from concentration to receptor. Because the entire source to dose continuum is deemed relevant in producing compatible results with high throughput toxicity testing how the results from far-field and near field source models can be combined warrants further exploration, especially because inverse associations were observed in some cases. A further consideration is whether a consensus approach should be developed or an approach that synthesizes the results from models across the source to dose continuum. Equal treatment of chemicals by each model demonstrated by the Friedman test may inform the appropriateness of consensus building when exposure source and pathway considerations are reconciled.
As highlighted by the RAIDAR results, the incorporation of internal exposure in prioritization schemes acknowledging the complexity of exposure is an important topic for exploration. For example, the rankings based on intake fraction vs. internal dose from the challenge results, show that incorporating ADME into prioritization. In other words, in many cases the precise pathway of exposure becomes relatively less important in determining tissue concentrations compared to the efficiency of absorption and the residence time in the body.
The authors recognize some additional factors for consideration in developing exposure based prioritization approaches that fell outside of the scope of modeling results herein. These issues are bulleted below:
 Consideration of chemicals as single substances rather than embedded in products a.
The issue of confidentiality of individual product usage data is a problem. b.
There is a separation in the product chain between the companies that make the chemical and the companies making the final products. c.
Those reporting production volume for a chemical are often unaware of how it may be used downstream. d.
Decisions on how chemicals may be used are sometimes made by many different smaller companies (formulators) rather than by large manufacturers who are used to working with regulators to provide information for exposure assessment.  The amount of the chemical released vs. the amount used vs. the amount produced may lead to different prioritization results.  In terms of modeling, an extension of exposure characterization beyond occurrence, persistence and bioaccumulation is necessary for prioritization of large numbers of chemicals.  Consideration of the potential lifetime of the person and the products  Should the function of the chemical or types of products it is used in (toys, paints, etc.) be the basis for exploring exposure scenarios?
Conclusions
Currently available approaches show promise for prioritizing chemical ingredients in products according to their potential for exposure, but several gaps in knowledge exist. Chief among these gaps are the paucity of information needed for reliable estimates of exposures for direct and micro- 
